Charoenwoodhipong Prae, Harlow Sioban D, Marder Wendy, Hassett Afton L, McCune W Joseph, Gordon Caroline, Helmick Charles G, Barbour Kamil E, Wang Lu, Mancuso Peter, Somers Emily C, Zick Suzanna M
University of Michigan, Ann Arbor.
University of Birmingham, Birmingham, UK.
Arthritis Care Res (Hoboken). 2020 Jul;72(7):874-881. doi: 10.1002/acr.23925.
To examine associations between dietary intake of omega-3 (n-3; generally antiinflammatory) and omega-6 (n-6; generally proinflammatory) fatty acids and patient-reported outcomes in systemic lupus erythematosus (SLE).
This study was based on the population-based Michigan Lupus Epidemiology and Surveillance cohort. Estimates of n-3 and n-6 intake were derived from Diet History Questionnaire II items (past year with portion size version). Patient-reported outcomes included self-reported lupus activity (Systemic Lupus Activity Questionnaire [SLAQ]). Multivariable regression, adjusted for age, sex, race, and body mass index, was used to assess associations between absolute intake of n-3 and n-6, as well as the n-6:n-3 ratio, and patient-reported outcomes.
Among 456 SLE cases, 425 (93.2%) were female, 207 (45.4%) were African American, and the mean ± SD age was 52.9 ± 12.3 years. Controlling for potential confounders, the average SLAQ score was significantly higher by 0.3 points (95% confidence interval [95% CI] 0.1, 0.6; P = 0.013) with each unit increase of the n-6:n-3 ratio. Both lupus activity and Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scores were lower with each 1-gram/1,000 kcal increase of n-3 fatty acids (SLAQ regression coefficient β = -0.8 [95% CI -1.6, 0.0]; P = 0.055; PROMIS sleep β = -1.1 [95% CI -2.0, -0.2]; P = 0.017). Higher n-3 intakes were nonsignificantly associated with lower levels of depressive symptoms and comorbid fibromyalgia, and with higher quality of life, whereas results for the n6:n3 ratio trended in the opposite direction.
This population-based study suggests that higher dietary intake of n-3 fatty acids and lower n-6:n-3 ratios are favorably associated with patient-reported outcomes in SLE, particularly self-reported lupus activity and sleep quality.
研究ω-3(n-3;一般具有抗炎作用)和ω-6(n-6;一般具有促炎作用)脂肪酸的饮食摄入量与系统性红斑狼疮(SLE)患者报告结局之间的关联。
本研究基于以人群为基础的密歇根狼疮流行病学与监测队列。n-3和n-6摄入量的估计值来自饮食历史问卷II项目(过去一年采用分量版本)。患者报告结局包括自我报告的狼疮活动度(系统性狼疮活动问卷[SLAQ])。采用多变量回归分析,对年龄、性别、种族和体重指数进行校正,以评估n-3和n-6的绝对摄入量、以及n-6:n-3比值与患者报告结局之间的关联。
在456例SLE病例中,425例(93.2%)为女性,207例(45.4%)为非裔美国人,平均年龄±标准差为52.9±12.3岁。在控制潜在混杂因素后,n-6:n-3比值每增加一个单位,平均SLAQ评分显著升高0.3分(95%置信区间[95%CI]0.1,0.6;P = 0.013)。n-3脂肪酸每增加1克/1000千卡,狼疮活动度和患者报告结局测量信息系统(PROMIS)睡眠障碍评分均降低(SLAQ回归系数β = -0.8[95%CI -1.6,0.0];P = 0.055;PROMIS睡眠β = -1.1[95%CI -2.0,-0.2];P = 0.017)。较高的n-3摄入量与较低水平的抑郁症状和合并纤维肌痛无显著关联,与较高的生活质量有非显著关联,而n6:n3比值的结果则呈相反趋势。
这项基于人群的研究表明,较高的n-3脂肪酸饮食摄入量和较低的n-6:n-3比值与SLE患者报告结局呈正向关联,尤其是自我报告的狼疮活动度和睡眠质量。